Literature DB >> 22715137

The effects of ultrasound and light on indocyanine-green-treated tumour cells and tissues.

Nikolitsa Nomikou1, Christine Sterrett, Ciara Arthur, Bridgeen McCaughan, John F Callan, Anthony P McHale.   

Abstract

Photodynamic therapy (PDT) is emerging as a treatment modality for the management of neoplastic disease. Despite considerable clinical success, its application for the treatment of deep-seated lesions is constrained by the inability of visible light to penetrate deeply into tissues. An emerging alternative approach exploits the fact that many photosensitisers respond to ultrasound, eliciting cytotoxic effects on target cells and tissues; this has become known as sonodynamic therapy (SDT). The objectives of this study were 1) to determine whether the IR-absorbing dye, indocyanine green (ICG), can be employed as a sonosensitiser and 2) to determine whether ultrasound can be used to enhance ICG-mediated PDT. Exposing ICG-treated mouse fibrosarcoma cells to ultrasound at an energy density of 30 J cm(-2) decreased cell viability by 65 %. Prior exposure of ICG-treated cells to light (λ 830 nm) and subsequent treatment with ultrasound led to a 90 % decrease in cell viability. In combination treatments a synergistic effect was observed at lower doses of ultrasound. Microscopic examination of cell populations treated with light or ultrasound demonstrated the production of intracellular reactive oxygen species (ROS). Using a mouse tumour model, treatment with light, ultrasound, or a combination thereof led to respective decreases in tumour growth of 42, 67, and 98 % at day 27 post-treatment. These results could provide a means of circumventing light-penetration issues that currently challenge the widespread use of PDT in the treatment of cancer.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715137     DOI: 10.1002/cmdc.201200233

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

Review 1.  Current status and future perspective of sonodynamic therapy for cancer.

Authors:  Atsushi Sofuni; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2022-10-12       Impact factor: 1.878

2.  Ultrasound-triggered oxygen-loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy.

Authors:  Harriet Lea-Banks; Sheng-Kai Wu; Hannah Lee; Kullervo Hynynen
Journal:  Nanotheranostics       Date:  2022-06-27

Review 3.  Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors.

Authors:  Mingying Yang; Tao Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-10       Impact factor: 15.336

Review 4.  Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers.

Authors:  Zhuoran Gong; Zhifei Dai
Journal:  Adv Sci (Weinh)       Date:  2021-03-12       Impact factor: 16.806

5.  Recent advances of sonodynamic therapy in cancer treatment.

Authors:  Guo-Yun Wan; Yang Liu; Bo-Wei Chen; Yuan-Yuan Liu; Yin-Song Wang; Ning Zhang
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

6.  Oxygen and indocyanine green loaded phase-transition nanoparticle-mediated photo-sonodynamic cytotoxic effects on rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Qin Tang; Jianyu Cui; Zhonghua Tian; Jiangchuan Sun; Zhigang Wang; Shufang Chang; Shenyin Zhu
Journal:  Int J Nanomedicine       Date:  2017-01-09

7.  The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.

Authors:  Wan Xie; Shenyin Zhu; Biyong Yang; Chunyan Chen; Shuning Chen; Yujiao Liu; Xuyuan Nie; Lan Hao; Zhigang Wang; Jiangchuan Sun; Shufang Chang
Journal:  Int J Nanomedicine       Date:  2019-12-02

8.  Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.

Authors:  Thuy Giang Nguyen Cao; Ji Hee Kang; Wangyu Kim; Junha Lim; Su Jin Kang; Jae Young You; Quan Truong Hoang; Won Jong Kim; Won Jong Rhee; Chulhong Kim; Young Tag Ko; Min Suk Shim
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

9.  Effect of hematoporphyrin monomethyl ether-sonodynamic therapy (HMME-SDT) on hypertrophic scarring.

Authors:  Hanjun Zhang; Xing Liu; Youbin Liu; Yin Wu; Hongxi Li; Chengbin Zhao; Huazhe Li; Qinggang Meng; Wei Li
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Dual-mode imaging and therapeutic effects of drug-loaded phase-transition nanoparticles combined with near-infrared laser and low-intensity ultrasound on ovarian cancer.

Authors:  Shuning Chen; Yujiao Liu; Shenyin Zhu; Chunyan Chen; Wan Xie; Linlin Xiao; Yi Zhu; Lan Hao; Zhigang Wang; Jiangchuan Sun; Shufang Chang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.